TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22464581

Group type: EXPERIMENTAL
Intervention: Intensive blood glucose control (group A, n = 35)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Active blood glucose control (group B, n = 38)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Common glucose control (group C, n = 29)
Number of subjects: 102
Study: 19715451

Group type: EXPERIMENTAL
Intervention: CO2 laser technique
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional surgery using a scalpel
Number of subjects: 43
Study: 18502162

Group type: EXPERIMENTAL
Intervention: recombinant human arylsulfatase B (rhASB) at 1 mg/kg weekly infusions
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: recombinant human arylsulfatase B (rhASB)
Number of subjects: 56

Group type: COMPARATOR
Intervention: placebo/rhASB
Number of subjects: 56
Study: 15895275

Group type: EXPERIMENTAL
Intervention: Subcutaneous IFNbeta‐1b (Betaferon) treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study: 12233808

Group type: EXPERIMENTAL
Intervention: Ginger syrup (1 tablespoon in 4 to 8 ounces of hot or cold water, 4 times daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo syrup (1 tablespoon in 4 to 8 ounces of hot or cold water, 4 times daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ginger syrup
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 26
Study: 9705036

Group type: EXPERIMENTAL
Intervention: Exercise (blood lactate threshold exercise using a cycle ergometer for 60 min three times a week for 4 weeks)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 29

Group type: COMPARATOR
Intervention: Non-exercise (control group)
Number of subjects: 29
Study: 7778813

Group type: EXPERIMENTAL
Intervention: Cephalosporine 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cephalosporine 1 (5-day administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cephalosporine 2 (2-day treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics for clean, planned surgery (grade II)
Number of subjects: 0
Study: 2531557

Group type: EXPERIMENTAL
Intervention: 10 micrograms.kg‐1 sufentanil as an induction dose plus 0.15 microgram.kg‐1.min‐1 continuous infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 10 micrograms.kg‐1 sufentanil as an induction dose plus 0.3 microgram.kg‐1.min‐1 continuous infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control values during sternotomy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EEG analysis during sufentanil anesthesia
Number of subjects: 20
Study: 1078528

Group type: EXPERIMENTAL
Intervention: Intensive nutrition consultation
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 31253252

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Spinal Manipulation Therapy (SMT)
Number of subjects: 100
Study: 25378096

Group type: EXPERIMENTAL
Intervention: Standard physiotherapy plus visceral manipulation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard physiotherapy plus placebo visceral manipulation
Number of subjects: 64
Study: 24369785

Group type: EXPERIMENTAL
Intervention: Nutritional intervention and physical training (fluid intake, protein and energy intake, strength training, increasing baseline activities)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Home visits without any intervention
Number of subjects: 80
Study: 21575503

Group type: EXPERIMENTAL
Intervention: CPT‐11 + CAP (irinotecan plus capecitabine)
Number of subjects: 63

Group type: COMPARATOR
Intervention: L‐OHP + CAP (oxaliplatin plus capecitabine)
Number of subjects: 63
Study: 18022709

Group type: EXPERIMENTAL
Intervention: Geriatric care unit
Number of subjects: 143
Study: 16626718

Group type: EXPERIMENTAL
Intervention: Drape estimation of blood loss
Number of subjects: 123

Group type: COMPARATOR
Intervention: Visual estimation of blood loss
Number of subjects: 123
Study: 15119989

Group type: EXPERIMENTAL
Intervention: GAL 24 mg (12 mg BID)
Number of subjects: 1698

Group type: EXPERIMENTAL
Intervention: GAL 16 mg (8 mg BID)
Number of subjects: 1698

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1698
Study: 11574383

Group type: EXPERIMENTAL
Intervention: Puncture of the cephalic vein 12 cm or more proximal to the styloid process of the radius
Number of subjects: 33

Group type: COMPARATOR
Intervention: Cephalic vein puncture at random locations
Number of subjects: 33
Study: 9773664

Group type: EXPERIMENTAL
Intervention: Tirilazad mesylate 6 mg/kg/day for 10 days
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Vehicle treatment
Number of subjects: 1023
Study: 8064733

Group type: EXPERIMENTAL
Intervention: S-adenosylmethionine (SAM) intravenous boluses of 400 mg for 5 days, followed by oral tablets, 200 mg thrice daily for 23 days
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo regimen
Number of subjects: 81
Study: 3069750

Group type: EXPERIMENTAL
Intervention: Fenticonazole vaginal ovules 200 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Fenticonazole vaginal ovules 600 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Fenticonazole vaginal ovules 1,000 mg
Number of subjects: 42
Study: 31687884

Group type: EXPERIMENTAL
Intervention: Inpatient multidisciplinary rehabilitation (MDR)
Number of subjects: 427
Study: 31075662

Group type: COMPARATOR
Intervention: Control downhill running at -6 degrees inclination (CON-6)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cadence -10%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control normal level running at 0 degrees inclination (CON-0)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cadences +/5%
Number of subjects: 40
Study: 29078966

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) on PC6 acupuncture point
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (steps reversed)
Number of subjects: 40
Study: 25330466

Group type: EXPERIMENTAL
Intervention: Self-compassion intervention (food planning plus self-compassion exercises)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Behaviourally based intervention (food planning plus behavioural strategies)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 41
Study: 23680007

Group type: EXPERIMENTAL
Intervention: Steamed bread made from Jizi439
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mixture of white grain bread wheat
Number of subjects: 20

Group type: COMPARATOR
Intervention: Buckwheat
Number of subjects: 20

Group type: COMPARATOR
Intervention: Steamed bread made from Chu20
Number of subjects: 20
Study: 22104156

Group type: EXPERIMENTAL
Intervention: Involved-field irradiation (IFI)
Number of subjects: 102
Study: 18275361

Group type: EXPERIMENTAL
Intervention: Compressed air massage (15-20 min daily at 1 bar pressure, 5 days a week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard medical and surgical management
Number of subjects: 60
Study: 16944005

Group type: EXPERIMENTAL
Intervention: Rofecoxib (Vioxx)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 11916198

Group type: EXPERIMENTAL
Intervention: Induction therapy (6 MIU interferon-alpha-2a daily for 4 weeks followed by 3 MIU thrice weekly for 22 weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard interferon therapy (3 MIU interferon-alpha-2a thrice weekly for 26 weeks)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Induction therapy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard interferon therapy
Number of subjects: 71
Study: 10091835

Group type: EXPERIMENTAL
Intervention: Meal rich in used cooking fat (fat 64.4 g)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Meal rich in unused cooking fat (fat 64.4 g)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low fat meal (fat 18.4 g)
Number of subjects: 10
Study: 7495927

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: GH-releasing hormone (GHRH)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Somatomedin‐C (Sm‐C) plasma concentrations
Number of subjects: 24

Group type: COMPARATOR
Intervention: Baseline GH concentrations
Number of subjects: 24
Study: 2406126

Group type: EXPERIMENTAL
Intervention: Child-centered, family-focused educational program (4 sessions of 1.5 hours each)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Traditional lecture format (3 sessions of 2 hours each)
Number of subjects: 236
Study: 7208542

Group type: EXPERIMENTAL
Intervention: Iron poly (sorbitol‐gluconic acid) complex (IPSG) 250 mg elemental iron per week for 8 weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Iron poly (sorbitol‐gluconic acid) complex (IPSG) 500 mg elemental iron per week for 8 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Iron dextran
Number of subjects: 11

Group type: COMPARATOR
Intervention: Iron sorbitol citrate
Number of subjects: 11
Study: 6831362

Group type: EXPERIMENTAL
Intervention: Levamisole (45 mg/m2, orally, twice daily for three consecutive days each week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chemotherapy alone (daunorubicin and cytosine arabinoside for induction and consolidation, methotrexate with citrovorum factor reversal, thioguanine and cytosine arabinoside for late intensification)
Number of subjects: 60
Study: 30560280

Group type: EXPERIMENTAL
Intervention: Combined cataract surgery with implantation of 2 iStents inject GTS-400
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard cataract surgery without stent implantation
Number of subjects: 65
Study: 28965725

Group type: EXPERIMENTAL
Intervention: Cut-and-sew Maze III procedure plus mitral valve replacement (MVR)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Mitral valve replacement alone (non-Maze)
Number of subjects: 130
Study: 26196201

Group type: EXPERIMENTAL
Intervention: 10,000 IU of oral vitamin D3/10 kg body weight per week for 6 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5000 IU of oral vitamin D3/10 kg body weight per week for 6 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 32
Study: 25012515

Group type: EXPERIMENTAL
Intervention: CX157 treatment
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360

Group type: COMPARATOR
Intervention: mITT population
Number of subjects: 360
Study: 22273828

Group type: EXPERIMENTAL
Intervention: Ramosetron 6 μg/kg
Number of subjects: 405

Group type: COMPARATOR
Intervention: Ramosetron 6 μg/kg and midazolam 0.1 mg/kg
Number of subjects: 405
Study: 20072036

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 17919233

Group type: EXPERIMENTAL
Intervention: High-dose PegIFN-alpha-2b (3.0 microg/kg once weekly for 12 weeks, then 2.0 microg/kg once weekly for 12 weeks, then 1.5 microg/kg once weekly for 48 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard regimen of PegIFN-alpha-2b (1.5 microg/kg once weekly for 48 weeks)
Number of subjects: 53
Study: 15619603

Group type: EXPERIMENTAL
Intervention: Ketoprofen (100 mg) before induction of anaesthesia (group K1)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Propacetamol (2 g) before induction of anaesthesia (group P1)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Saline before surgery and ketoprofen (100 mg) after surgery (group K2)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Saline before surgery and propacetamol (2 g) after surgery (group P2)
Number of subjects: 104
Study: 12233968

Group type: EXPERIMENTAL
Intervention: Intercostal bupivacaine with epinephrine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 47
Study: 10088167

Group type: EXPERIMENTAL
Intervention: Nasal spray (large-particle aerosol)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Nose drops
Number of subjects: 3
Study: 7493058

Group type: EXPERIMENTAL
Intervention: Perfluoroctylbromide (PFOB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PFOB
Number of subjects: 0
Study: 2189843

Group type: EXPERIMENTAL
Intervention: Adjuvant local graft irradiation (600 cGy in four fractions) with chemical immunosuppression
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (chemical immunosuppression only)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Adjuvant local graft irradiation
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 138
Study: 465281

Group type: EXPERIMENTAL
Intervention: Aspirin (1280 mg each)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dimenhydrinate (Dramamine) (100 mg each)
Number of subjects: 16
Study: 31005431

Group type: EXPERIMENTAL
Intervention: Anterior-Stabilized (AS) TKA
Number of subjects: 45

Group type: COMPARATOR
Intervention: Posterior-Stabilized (PS) TKA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: AS TKA
Number of subjects: 45

Group type: COMPARATOR
Intervention: PS TKA
Number of subjects: 45
Study: 29557562

Group type: EXPERIMENTAL
Intervention: Bipolar diathermy-assisted coblation tonsillectomy
Number of subjects: 1684

Group type: COMPARATOR
Intervention: Coblation tonsillectomy (control)
Number of subjects: 1684
Study: 25872780

Group type: EXPERIMENTAL
Intervention: Open strategy (surgical cut-down of the cephalic vein, with rescue technique if necessary)
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Direct puncture of the subclavian vein using the Seldinger technique guided by sonography, fluoroscopy or landmark technique
Number of subjects: 1154
Study: 23684482

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 22017620

Group type: EXPERIMENTAL
Intervention: naproxen/esomeprazole magnesium
Number of subjects: 1234
Study: 19626694

Group type: EXPERIMENTAL
Intervention: Fluoroscopic guidance (FG)
Number of subjects: 972

Group type: COMPARATOR
Intervention: Traditional anatomic landmark guidance (TALG)
Number of subjects: 972
Study: 16939527

Group type: EXPERIMENTAL
Intervention: Educational intervention (specific lecture + small working group seminars)
Number of subjects: 367
Study: 15049387

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 90

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 90
Study: 11880912

Group type: EXPERIMENTAL
Intervention: Wrap
Number of subjects: 39

Group type: COMPARATOR
Intervention: Walking cast
Number of subjects: 39
Study: 10438985

Group type: EXPERIMENTAL
Intervention: Glucose-free medium
Number of subjects: 741

Group type: COMPARATOR
Intervention: Glucose medium
Number of subjects: 741
Study: 8553350

Group type: EXPERIMENTAL
Intervention: Frequent hard physical activities
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control for age, BMI, dietary factors, smoking status, serum total cholesterol and serum triglycerides
Number of subjects: 131
Study: 2178493

Group type: EXPERIMENTAL
Intervention: Epidural clonidine (2 micrograms/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intramuscular clonidine (2 micrograms/kg)
Number of subjects: 20
Study: 6775303

Group type: EXPERIMENTAL
Intervention: pentaerythritol tetranitrate (PETN) 80 mg 8-hourly
Number of subjects: 31

Group type: COMPARATOR
Intervention: dipyramidole (DPM) 75 mg
Number of subjects: 31
Study: 29917154

Group type: EXPERIMENTAL
Intervention: Vignette‐based analyses of adverse events conducted once per month for six consecutive months
Number of subjects: 401

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 401
Study: 29417699

Group type: EXPERIMENTAL
Intervention: Faradic current for 10 min and task-oriented exercises
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Russian current for 10 min and task-oriented exercises
Number of subjects: 83

Group type: COMPARATOR
Intervention: Task-oriented exercises
Number of subjects: 83
Study: 26553159

Group type: EXPERIMENTAL
Intervention: Testosterone treatment (24 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo treatment (24 weeks)
Number of subjects: 44
Study: 24439653

Group type: EXPERIMENTAL
Intervention: Mouth rinse with pomegranate and chamomile plant extracts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorhexidine 0.12%
Number of subjects: 0
Study: 22721424

Group type: EXPERIMENTAL
Intervention: Individually tailored 12-week home-based exercise training program (interval training on a treadmill and strength training)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 30
Study: 21180216

Group type: EXPERIMENTAL
Intervention: Phenylephrine 25 microgram
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ephedrine 5mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mephentermine 6mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 90
Study: 17981851

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 15246912

Group type: EXPERIMENTAL
Intervention: SLV306 (200 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SLV306 (400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SLV306 (800 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SLV306 (all doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SLV306
Number of subjects: 0
Study: 12014484

Group type: EXPERIMENTAL
Intervention: Viewing distance of 0.4 m
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viewing distance of 1 m
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viewing distance of 1.5 m
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viewing distance of 3 m
Number of subjects: 0
Study: 9509213

Group type: EXPERIMENTAL
Intervention: EMLA cream (Group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo cream (Group B)
Number of subjects: 42
Study: 8092509

Group type: EXPERIMENTAL
Intervention: Sevoflurane for laryngeal mask airway insertion (MACLMI)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Sevoflurane for tracheal intubation (MACTI)
Number of subjects: 42
Study: 3289804

Group type: COMPARATOR
Intervention: Immunosuppressants (corticosteroids, cyclophosphamide, azathioprine)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Immunosuppressants (corticosteroids, cyclophosphamide, azathioprine) + Plasma exchange therapy
Number of subjects: 26
Study: 30015546

Group type: EXPERIMENTAL
Intervention: Mid-thoracic manipulation (MTM)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham intervention (Control)
Number of subjects: 23
Study: 29287674

Group type: EXPERIMENTAL
Intervention: NIRS monitoring
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional monitoring (control group)
Number of subjects: 40
Study: 26891101

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 42

Group type: COMPARATOR
Intervention: Salt mouth rinse
Number of subjects: 42

Group type: COMPARATOR
Intervention: Citric acid mouth rinse
Number of subjects: 42

Group type: COMPARATOR
Intervention: De-ionised water mouth rinse
Number of subjects: 42
Study: 25633123

Group type: EXPERIMENTAL
Intervention: Traditional Ponseti method (one cast a week)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Accelerated Ponseti technique (casting twice a week)
Number of subjects: 41
Study: 24429129

Group type: EXPERIMENTAL
Intervention: Lung volume reduction coils (LVRCs)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Best medical care (usual care)
Number of subjects: 47
Study: 20874740

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) 0.25 mg/kg twice daily at postnatal day 1 and 2
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 54
Study: 18929194

Group type: EXPERIMENTAL
Intervention: Simple decompression
Number of subjects: 449

Group type: COMPARATOR
Intervention: Anterior transposition (subcutaneous or submuscular)
Number of subjects: 449
Study: 16622804

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 60
Study: 15011734

Group type: EXPERIMENTAL
Intervention: Nicotine transdermal patches (17.5 mg/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo transdermal patches
Number of subjects: 11
Study: 10920613

Group type: EXPERIMENTAL
Intervention: Mycobacterium w vaccine
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 8820806

Group type: EXPERIMENTAL
Intervention: Immediate mandibular overdentures on two mandibular canines with magnetic attachments
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Immediate mandibular overdentures on two mandibular canines without magnetic attachments
Number of subjects: 74

Group type: COMPARATOR
Intervention: Complete immediate dentures
Number of subjects: 74
Study: 8339079

Group type: EXPERIMENTAL
Intervention: Topical PROCUREN (autologous platelet-derived wound healing factors)
Number of subjects: 0
Study: 2947151

Group type: EXPERIMENTAL
Intervention: Trimetazidine 60 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 30560818

Group type: EXPERIMENTAL
Intervention: Resin infiltration
Number of subjects: 23

Group type: COMPARATOR
Intervention: Fluoride varnish
Number of subjects: 23
Study: 27881151

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 720

Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 720
Study: 26557261

Group type: EXPERIMENTAL
Intervention: Fluticasone (FP) 500 µg bid, five doses total
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 23497111

Group type: EXPERIMENTAL
Intervention: Triple therapy (methotrexate + sulfasalazine + hydroxychloroquine)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: MTX + INF (methotrexate + infliximab)
Number of subjects: 159

Group type: COMPARATOR
Intervention: MTX responders (control group)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: MTX responders (triple therapy)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: MTX + INF
Number of subjects: 159
Study: 21622589

Group type: EXPERIMENTAL
Intervention: Exercise training (5 times a week for 6 weeks)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 72
Study: 18343702

Group type: EXPERIMENTAL
Intervention: 24-hour therapy with artesunate/sulfamethoxypyrazine/pyrimethamine (As/SMP)
Number of subjects: 221

Group type: COMPARATOR
Intervention: 3-day therapy with artesunate/sulfamethoxypyrazine/pyrimethamine (As/SMP)
Number of subjects: 221
Study: 16417952

Group type: EXPERIMENTAL
Intervention: MCV-4 (meningococcal diphtheria toxoid conjugate vaccine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hib vaccine (control group)
Number of subjects: 0